<DOC>
	<DOCNO>NCT01242371</DOCNO>
	<brief_summary>The investigator intend explore hypothesis symptom schizophrenia may reduce administration probiotic supplement use addition standard antipsychotic medication .</brief_summary>
	<brief_title>Double-Blind Trial Probiotic Supplement Reduce Symptoms Schizophrenia</brief_title>
	<detailed_description>The primary aim current study : 1 . To evaluate safety efficacy supplemental probiotic therapy , contain microorganism Lactobacillus rhamnosus GG Bifidobacterium lanimalis subsp . lactis ( BB12 ) , individual schizophrenia residual psychotic symptom least moderate severity . Secondary aim study : 2 . To assess effect probiotic treatment patient ' gastrointestinal functioning 3 . To study effect probiotic treatment lowering level antibody casein gliadin . 4 . To investigate association efficacy probiotic therapy initial level antibody gliadin casein .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>Age 1865 . Capacity write informed consent . Primary Axis I diagnosis ( DSMIV ) schizophrenia , type , OR schizoaffective disorder ( APA , 1994 ) . Currently outpatient time enrollment . Residual psychotic symptom least moderately severe evidence one PANSS positive symptom score , and/or PANSS negative symptom score 4 ; OR total PANSS score 50 , contain least three positive negative item score 3 screening . Conformance PORT Treatment Recommendation Maintenance Antipsychotic Medication Dose ( Buchanan et al. , 2010 ) . Receiving antipsychotic medication least 8 week prior start study medication change within previous 21 day . Proficient English language . Diagnosis mental retardation . Any clinically significant unstable medical disorder determine investigator , include congestive heart failure , abnormal liver function disease , renal failure , acute pancreatitis , diagnosis cancer undergo active treatment , HIV infection immunodeficiency condition . History IV drug use . Primary diagnosis substance abuse dependence accord DSMIV criterion within last three month . Participated investigational drug trial past 30 day . Pregnant plan become pregnant study period . Receipt antibiotic medication within previous 14 day ( anaerobic organism reside gastrointestinal tract may minimally affect antibiotic ) . Documented celiac disease ( person glutenfree diet standard care ) . Of note , investigator limit study individual elevate level gliadin casein antibody investigator intend look level predictor response .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective</keyword>
	<keyword>Probiotic supplement</keyword>
	<keyword>Gliadin</keyword>
	<keyword>Casein</keyword>
</DOC>